PHG 📈 Koninklijke Philips NV ADR - Overview

Exchange: NYSE • Country: Netherlands • Currency: USD • Type: Common Stock • ISIN: US5004723038

PHG: Medical Imaging, Patient Monitoring, Oral Care, Baby Care, Grooming

Koninklijke Philips NV is a health technology company with a global presence, operating in North America, the Greater China, and other international markets. The company's business is organized into three main segments: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. This structure enables Philips to provide a wide range of innovative solutions, from diagnostic imaging and patient monitoring to personal health and wellness products. For instance, its diagnostic imaging solutions include advanced technologies such as magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems, which are used to diagnose and treat various medical conditions.

The company's product portfolio is diverse and extensive, featuring a broad range of medical devices and software solutions. These include echography solutions for cardiology, general imaging, and obstetrics/gynecology, as well as integrated interventional systems and interventional diagnostic and therapeutic devices for treating coronary artery and peripheral vascular disease. Additionally, Philips offers acute patient management solutions, emergency care solutions, sleep and respiratory care solutions, and electronic medical record and care management solutions, all designed to improve patient outcomes and enhance the overall quality of care. Its personal health products, such as power toothbrushes, infant feeding solutions, and grooming and beauty products, cater to the everyday health and wellness needs of consumers.

Philips has established strategic partnerships with several prominent healthcare organizations, including TriHealth, Northwell, Atrium Health, Mayo Clinic, and Edith Cowan University. These collaborations enable the company to stay at the forefront of medical innovation, leveraging the expertise and resources of its partners to develop new solutions and improve existing ones. With a rich history dating back to 1891, Koninklijke Philips NV has evolved significantly over the years, transforming from a diversified electronics company to a focused health technology leader. Today, the company is headquartered in Amsterdam, the Netherlands, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol PHG, with its common stock classified under the GICS Sub Industry: Health Care Equipment.

As a leading health technology company, Philips is committed to delivering innovative solutions that improve people's lives. Its products and services are designed to make a positive impact on healthcare outcomes, patient experiences, and the overall efficiency of healthcare systems. With a strong foundation in research and development, Philips continues to invest in new technologies and collaborations, driving growth and expansion into new markets and segments. The company's website, https://www.philips.com, provides more information on its products, services, and initiatives, as well as its commitment to creating a healthier and more sustainable future for all.

Additional Sources for PHG Stock

PHG Stock Overview

Market Cap in USD 25,385m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Equipment
IPO / Inception 1987-12-30

PHG Stock Ratings

Growth 5y -33.7%
Fundamental -2.48%
Dividend 15.7%
Rel. Strength Industry 356
Analysts 4/5
Fair Price Momentum 22.70 USD
Fair Price DCF 39.78 USD

PHG Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 73.2%

PHG Growth Ratios

Growth Correlation 3m -83.9%
Growth Correlation 12m 70.2%
Growth Correlation 5y -63.9%
CAGR 5y -9.14%
CAGR/Mean DD 5y -0.23
Sharpe Ratio 12m 0.38
Alpha -12.09
Beta 0.95
Volatility 37.09%
Current Volume 563.1k
Average Volume 20d 622k
What is the price of PHG stocks?
As of December 21, 2024, the stock is trading at USD 25.11 with a total of 563,137 shares traded.
Over the past week, the price has changed by -2.34%, over one month by -3.62%, over three months by -19.02% and over the past year by +10.62%.
Is Koninklijke Philips NV ADR a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Koninklijke Philips NV ADR is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -2.48 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHG as of December 2024 is 22.70. This means that PHG is currently overvalued and has a potential downside of -9.6%.
Is PHG a buy, sell or hold?
Koninklijke Philips NV ADR has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy PHG.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PHG stock price target?
According to ValueRays Forecast Model, PHG Koninklijke Philips NV ADR will be worth about 24.9 in December 2025. The stock is currently trading at 25.11. This means that the stock has a potential downside of -0.84%.
Issuer Forecast Upside
Wallstreet Target Price 34.5 37.4%
Analysts Target Price 17.4 -30.5%
ValueRay Target Price 24.9 -0.8%